Skip to main content

Advertisement

Log in

Tc-99 m diethylenetriamine-pentaacetic acid (DTPA): is it reliable for assessment of methotrexate-induced cumulative effect on renal filtration in rheumatoid arthritis patients?

  • Short Communication
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Methotrexate (MTX) is commonly employed as the initial DMARD used for the treatment of rheumatoid arthritis (RA). We aimed to contribute to the safety profile of MTX by assessing its cumulative effect on renal filtration. A total of 52 RA adult female patients with normal baseline serum creatinine and GFR at the initial diagnosis of the disease were included. Group 1 (G1) included 30 patients (mean age 40.4 ± 4.4 years) on MTX and NSAIDS, while 22 RA patients (mean age 38.5 ± 8.2 years) who received NSAIDs only served as control group (G2). Renal function was assessed by GFR measurement using technetium diethylenetriamine-pentaacetic acid (Tc-99 m DTPA) at a point of the study time corresponding to disease duration. Twenty-one out of thirty (70 %) in G1 showed reduced GFR compared to 6/22 (27.3 %) in G2 (P = 0.007), with 3.3 ± 0.5 % annual reduction in GFR. Reduced GFR in G1 showed significant negative correlation with age (r = −0.396, P = 0.005), MTX cumulative dose (r = −0.263, P = 0.049), MTX-intake duration (r = −0.293, P = 0.031) and NSAIDs-intake duration (r = −0.344, P = 0.014). Low-dose MTX has a slow cumulative effect on renal filtration manifested by GFR reduction overtime that could be monitored by Tc-99 m DTPA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Capkin E, Cakirbay H, Karkucak M et al (2010) Prevalence of rheumatoid arthritis in the eastern Black Sea region of Turkey. Int J Rheum Dis 13:380–384

    Article  PubMed  Google Scholar 

  2. Karie S, Gandjbakhch F, Janus N et al (2008) Kidney disease in RA patients: prevalence and implications on RA related drug management: the MATRIX study. Rheumatol (Oxford) 47:350–354

    Article  CAS  Google Scholar 

  3. Imboden J (2007) Medications. In: Imboden J, HellMann D, Stone J (eds) Current rheumatology diagnosis and treatment, 2nd edn. The McGraw-Hill Companies, Inc, USA, pp 525–528

    Google Scholar 

  4. Weinblatt ME (2001) Methotrexate. In: Ruddy S, Harris ED, Sledge CB (eds) Kelley’s textbook of rheumatology, 6th edn. WB. Saunders Company, Philadelphia, pp 843, 846–849

  5. Rau R, Herborn G (2004) Benefit and risk of methotrexate treatment in rheumatoid arthritis. Clin Exp Rheumatol 22(Suppl 35):S83–S94

    CAS  PubMed  Google Scholar 

  6. Seideman P, Müller-Suur R, Ekman E (1993) Renal effects of low dose methotrexate in rheumatoid arthritis. J Rheumatol 20:1126–1128

    CAS  PubMed  Google Scholar 

  7. Chantler C, Garnett ES, Parsons V et al (1969) Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA. Clin Sci 37:169–180

    CAS  PubMed  Google Scholar 

  8. Harris K, Stribling B (2007) Automated estimated GFR reporting: a new tool to promote safer prescribing in patients with chronic kidney disease? Ther Clin Risk Manag 3:969–972

    PubMed  Google Scholar 

  9. Perrone RD, Steinman TI, Beck GJ et al (1990) Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The modification of diet in renal disease study. Am J Kidney Dis 16:224–235

    CAS  PubMed  Google Scholar 

  10. Kingdon EJ, Knight CJ, Dustan K et al (2003) Calculated glomerular filtration rate is a useful screening tool to identify scleroderma patients with renal impairment. Rheumatol (Oxford) 42:26–33

    Article  CAS  Google Scholar 

  11. Weinblatt ME (1996) Methotrexate in rheumatoid arthritis: toxicity issues. Br J Rheumatol 35:403–405

    Article  CAS  PubMed  Google Scholar 

  12. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 31:315–324

    Article  CAS  Google Scholar 

  13. Prevoo ML, van’t Hof MA, Kuper HH et al (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthr Rheum 38:44–48

    Article  CAS  Google Scholar 

  14. Gates GF (1982) Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc-DTPA (stannous). AJR Am J Roentgenol 138:565–570

    Article  CAS  PubMed  Google Scholar 

  15. National Kidney Foundation Kidney Disease, Outcome Quality Initiative Advisory Board (2002) Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Kidney disease quality initiative: Staging system and action planes for chronic kidney disease. Am J of kidney disease, 39 (suppl 2):SI–246

  16. Coresh J, Auguste P (2008) Reliability of GFR formulas based on serum creatinine, with special reference to the MDRD Study equation. Scand J Clin Lab Invest Suppl 241:30–38

    Article  PubMed  Google Scholar 

  17. Mohamed RH, Zayed HS, Amin A (2010) Renal disease in systemic sclerosis with normal serum creatinine. Clin Rheumatol 29:729–737

    Article  PubMed  Google Scholar 

  18. Gutte H, Møller ML, Pfeifer AK et al (2010) Estimating GFR in children with 99mTc-DTPA renography: a comparison with single-sample 51Cr-EDTA clearance. Clin Physiol Funct Imaging 30:169–174

    Article  CAS  PubMed  Google Scholar 

  19. Verstappen SM, Bakker MF, Heurkens AH et al (2010) Utrecht Rheumatoid Arthritis Cohort Study Group. Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study. Ann Rheum Dis 69:1044–1048

    Article  CAS  PubMed  Google Scholar 

  20. Townsend RR (2008) Blood pressure raising effects of anti inflammatory drugs, angiogenesis inhibitors, and cholesterol-ester-transfer protein inhibitors. In: Izzo JL, Sica DA, Black HR (eds) Hypertension primer, 4th edn. Lippincott, William and Wilkins, USA, p 46

    Google Scholar 

  21. Harirforoosh S, Jamali F (2009) Renal adverse effects of nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf 8:669–681

    Article  CAS  PubMed  Google Scholar 

  22. Iqbal MP, Baig JA, Ali AA et al (1998) The effects of non-steroidal anti-inflammatory drugs on the disposition of methotrexate in patients with rheumatoid arthritis. Biopharm Drug Dispos 19:163–167

    Article  CAS  PubMed  Google Scholar 

  23. Fitzgerald GA, Patrono C (2005) The coxibs; selective inhibitors of cyclooxygenase-2. N Engl J Med 345:433–442. In: Cush JJ, Kavanaugh A, Stein CM (eds) Rheumatology diagnosis and therapeutics, 2nd edn. Lippincott Williams and Wilkins, USA, p 494

    Google Scholar 

  24. Daoussis D, Panoulas VF, Antonopoulos I et al (2010) Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis. Ann Rheum Dis 69:517–521

    Article  CAS  PubMed  Google Scholar 

  25. Amann K, Wanner C, Ritz E (2006) Cross-talk between the kidney and the cardiovascular system. J Am Soc Nephrol 17:2112–2119

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Dr. Zeinab Nawito for helpful contributions in the finalization of this work regarding clinical and grammatical aspects.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amr Amin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Amin, A., Effat, D., Goher, N. et al. Tc-99 m diethylenetriamine-pentaacetic acid (DTPA): is it reliable for assessment of methotrexate-induced cumulative effect on renal filtration in rheumatoid arthritis patients?. Rheumatol Int 33, 3059–3063 (2013). https://doi.org/10.1007/s00296-012-2620-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-012-2620-0

Keywords

Navigation